Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel Free CO Stock Alerts

Global Cord Blood (CO) Competitors

Global Cord Blood logo
$0.95 0.00 (0.00%)
As of 08/14/2026
Compare

CO vs. CCRN, CYH, AUNA, SBC, and VMD

Should you buy Global Cord Blood stock or one of its competitors? Global Cord Blood's main competitors and comparable companies include Cross Country Healthcare (CCRN), Community Health Systems (CYH), Auna (AUNA), SBC Medical Group (SBC), and Viemed Healthcare (VMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Global Cord Blood compare to Cross Country Healthcare?

Cross Country Healthcare (NASDAQ:CCRN) and Global Cord Blood (NYSE:CO) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, media sentiment, dividends, valuation, analyst recommendations, risk and earnings.

In the previous week, Cross Country Healthcare had 1 more articles in the media than Global Cord Blood. MarketBeat recorded 1 mentions for Cross Country Healthcare and 0 mentions for Global Cord Blood. Cross Country Healthcare's average media sentiment score of 0.00 equaled Global Cord Blood'saverage media sentiment score.

Company Overall Sentiment
Cross Country Healthcare Neutral
Global Cord Blood Neutral

Cross Country Healthcare has a beta of 0.45, indicating that its share price is 55% less volatile than the broader market. Comparatively, Global Cord Blood has a beta of 0.16, indicating that its share price is 84% less volatile than the broader market.

Global Cord Blood has a net margin of 0.00% compared to Cross Country Healthcare's net margin of -9.84%. Global Cord Blood's return on equity of 0.00% beat Cross Country Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Cross Country Healthcare-9.84% -0.74% -0.54%
Global Cord Blood N/A N/A N/A

96.0% of Cross Country Healthcare shares are owned by institutional investors. 6.3% of Cross Country Healthcare shares are owned by insiders. Comparatively, 0.5% of Global Cord Blood shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Cross Country Healthcare presently has a consensus price target of $12.05, indicating a potential downside of 9.06%. Given Cross Country Healthcare's stronger consensus rating and higher probable upside, research analysts clearly believe Cross Country Healthcare is more favorable than Global Cord Blood.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cross Country Healthcare
1 Sell rating(s)
9 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.90
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Global Cord Blood has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Global Cord Blood, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cross Country Healthcare$1.00B0.43-$94.85M-$3.05N/A
Global Cord Blood$1.24B0.09$79.04M$0.641.49

Summary

Cross Country Healthcare and Global Cord Blood tied by winning 7 of the 14 factors compared between the two stocks.

How does Global Cord Blood compare to Community Health Systems?

Community Health Systems (NYSE:CYH) and Global Cord Blood (NYSE:CO) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, media sentiment, earnings and profitability.

Community Health Systems has a net margin of 2.10% compared to Global Cord Blood's net margin of 0.00%. Global Cord Blood's return on equity of 0.00% beat Community Health Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Community Health Systems2.10% -6.66% 0.62%
Global Cord Blood N/A N/A N/A

Community Health Systems presently has a consensus price target of $2.95, indicating a potential downside of 1.83%. Given Community Health Systems' stronger consensus rating and higher probable upside, analysts clearly believe Community Health Systems is more favorable than Global Cord Blood.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Community Health Systems
3 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
1.71
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Community Health Systems has higher revenue and earnings than Global Cord Blood. Global Cord Blood is trading at a lower price-to-earnings ratio than Community Health Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Community Health Systems$11.98B0.04$509M$1.851.62
Global Cord Blood$1.24B0.09$79.04M$0.641.49

85.0% of Community Health Systems shares are held by institutional investors. 11.1% of Community Health Systems shares are held by company insiders. Comparatively, 0.5% of Global Cord Blood shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Community Health Systems has a beta of 1.84, meaning that its share price is 84% more volatile than the broader market. Comparatively, Global Cord Blood has a beta of 0.16, meaning that its share price is 84% less volatile than the broader market.

In the previous week, Community Health Systems' average media sentiment score of 0.00 equaled Global Cord Blood'saverage media sentiment score.

Company Overall Sentiment
Community Health Systems Neutral
Global Cord Blood Neutral

Summary

Community Health Systems beats Global Cord Blood on 12 of the 14 factors compared between the two stocks.

How does Global Cord Blood compare to Auna?

Global Cord Blood (NYSE:CO) and Auna (NYSE:AUNA) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, institutional ownership, valuation, dividends and profitability.

Global Cord Blood has a beta of 0.16, indicating that its share price is 84% less volatile than the broader market. Comparatively, Auna has a beta of 0.61, indicating that its share price is 39% less volatile than the broader market.

Auna has a net margin of 1.53% compared to Global Cord Blood's net margin of 0.00%. Auna's return on equity of 16.25% beat Global Cord Blood's return on equity.

Company Net Margins Return on Equity Return on Assets
Global Cord BloodN/A N/A N/A
Auna 1.53%16.25%4.03%

Global Cord Blood has higher earnings, but lower revenue than Auna. Global Cord Blood is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Global Cord Blood$1.24B0.09$79.04M$0.641.49
Auna$4.52B0.09$27.39M$0.2620.15

In the previous week, Auna had 2 more articles in the media than Global Cord Blood. MarketBeat recorded 2 mentions for Auna and 0 mentions for Global Cord Blood. Auna's average media sentiment score of 0.53 beat Global Cord Blood's score of 0.00 indicating that Auna is being referred to more favorably in the news media.

Company Overall Sentiment
Global Cord Blood Neutral
Auna Positive

Auna has a consensus target price of $6.97, suggesting a potential upside of 32.95%. Given Auna's stronger consensus rating and higher possible upside, analysts clearly believe Auna is more favorable than Global Cord Blood.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Auna
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.40

Summary

Auna beats Global Cord Blood on 12 of the 15 factors compared between the two stocks.

How does Global Cord Blood compare to SBC Medical Group?

SBC Medical Group (NASDAQ:SBC) and Global Cord Blood (NYSE:CO) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

SBC Medical Group currently has a consensus target price of $8.50, suggesting a potential upside of 132.24%. Given SBC Medical Group's stronger consensus rating and higher possible upside, equities analysts plainly believe SBC Medical Group is more favorable than Global Cord Blood.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

SBC Medical Group has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market. Comparatively, Global Cord Blood has a beta of 0.16, suggesting that its stock price is 84% less volatile than the broader market.

Global Cord Blood has higher revenue and earnings than SBC Medical Group. Global Cord Blood is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SBC Medical Group$175.17M2.14$50.99M$0.477.79
Global Cord Blood$1.24B0.09$79.04M$0.641.49

In the previous week, SBC Medical Group had 13 more articles in the media than Global Cord Blood. MarketBeat recorded 13 mentions for SBC Medical Group and 0 mentions for Global Cord Blood. SBC Medical Group's average media sentiment score of 0.09 beat Global Cord Blood's score of 0.00 indicating that SBC Medical Group is being referred to more favorably in the media.

Company Overall Sentiment
SBC Medical Group Neutral
Global Cord Blood Neutral

SBC Medical Group has a net margin of 27.99% compared to Global Cord Blood's net margin of 0.00%. SBC Medical Group's return on equity of 18.81% beat Global Cord Blood's return on equity.

Company Net Margins Return on Equity Return on Assets
SBC Medical Group27.99% 18.81% 13.49%
Global Cord Blood N/A N/A N/A

60.8% of SBC Medical Group shares are held by institutional investors. 81.7% of SBC Medical Group shares are held by insiders. Comparatively, 0.5% of Global Cord Blood shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

SBC Medical Group beats Global Cord Blood on 13 of the 16 factors compared between the two stocks.

How does Global Cord Blood compare to Viemed Healthcare?

Viemed Healthcare (NASDAQ:VMD) and Global Cord Blood (NYSE:CO) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings.

In the previous week, Viemed Healthcare had 3 more articles in the media than Global Cord Blood. MarketBeat recorded 3 mentions for Viemed Healthcare and 0 mentions for Global Cord Blood. Viemed Healthcare's average media sentiment score of 0.54 beat Global Cord Blood's score of 0.00 indicating that Viemed Healthcare is being referred to more favorably in the media.

Company Overall Sentiment
Viemed Healthcare Positive
Global Cord Blood Neutral

74.2% of Viemed Healthcare shares are held by institutional investors. 20.6% of Viemed Healthcare shares are held by company insiders. Comparatively, 0.5% of Global Cord Blood shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Global Cord Blood has higher revenue and earnings than Viemed Healthcare. Global Cord Blood is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Viemed Healthcare$301.61M1.16$14.93M$0.3625.56
Global Cord Blood$1.24B0.09$79.04M$0.641.49

Viemed Healthcare has a net margin of 4.81% compared to Global Cord Blood's net margin of 0.00%. Viemed Healthcare's return on equity of 10.16% beat Global Cord Blood's return on equity.

Company Net Margins Return on Equity Return on Assets
Viemed Healthcare4.81% 10.16% 7.22%
Global Cord Blood N/A N/A N/A

Viemed Healthcare has a beta of 1.1, suggesting that its stock price is 10% more volatile than the broader market. Comparatively, Global Cord Blood has a beta of 0.16, suggesting that its stock price is 84% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Viemed Healthcare
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Global Cord Blood
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Viemed Healthcare beats Global Cord Blood on 12 of the 15 factors compared between the two stocks.

Get Global Cord Blood News Delivered to You Automatically

Sign up to receive the latest news and ratings for CO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CO vs. The Competition

Export
MetricGlobal Cord BloodHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$115.60M$9.81B$7.04B$24.30B
Dividend YieldN/A2.55%2.57%3.68%
P/E Ratio1.4935.17270.1730.85
Price / Sales0.094.72574.4266.92
Price / Cash4.19124.3470.4832.80
Price / Book0.153.9412.916.82
Net Income$79.04M$309.96M$3.45B$1.06B
7 Day PerformanceN/A0.09%1.15%0.55%
1 Month Performance0.11%-0.33%1.37%2.90%
1 Year Performance72.91%19.52%62.52%19.10%

Global Cord Blood Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CO
Global Cord Blood
N/A$0.95
flat		N/A+72.9%$115.60M$1.24B1.491,202
CCRN
Cross Country Healthcare
1.6206 of 5 stars		$13.25
flat		$12.05
-9.1%		N/A$428.05M$1.00BN/A6,784
CYH
Community Health Systems
1.1501 of 5 stars		$3.02
+1.5%		$2.95
-2.2%		+9.9%$425.15M$12.49B1.6357,000
AUNA
Auna
4.6787 of 5 stars		$5.35
+1.2%		$6.97
+30.1%		-17.6%$396.69M$1.23B20.6215,254
SBC
SBC Medical Group
3.4248 of 5 stars		$3.46
+8.5%		$8.50
+145.7%		-9.9%$354.93M$173.61M8.87N/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:CO) was last updated on 8/15/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel